Our Team

John W. Park, MD

Medical Oncologist
Associate Clinical Professor, Departments of Medicine and Neurological Surgery
Director, Novel Therapeutics in Breast Oncology
Co-director, UCSF Breast SPORE Program

Biography

Dr. Park is a hematologist-oncologist whose research interests include novel targeted therapies of cancer, monoclonal antibody therapy, liposome- and nanoparticle-based drug delivery, and metastasis and micrometastasis. He has been the recipient of multiple honors and awards, including the American Society of Clinical Oncology (ASCO) Young Investigator Award and the Career Development Award from the Department of Defense Breast Cancer Research Program.

Dr. Park's research has been extensively published in leading journals such as Science, Journal of Clinical Oncology, Cancer Research, Clinical Cancer Research, Oncogene, Journal of Biological Chemistry, Biochemistry, Biochem. Biophys. Acta (BBA), Journal of Cell Science, Cytometry, Advances in Pharmacology, Biochemical Pharmacology, Biotechnology Progress, Journal of Controlled Release, Seminars in Oncology, Breast Cancer Research and Treatment, Breast Cancer Research, Journal of NeuroOncology, Cancer, The Cancer Journal, and Annals of Internal Medicine.

In addition to his academic position, Dr. Park has extensive experience in biotechnology and drug development. Dr. Park was a postdoctoral fellow and Visiting Scientist at Genentech, Inc. from 1990 to 1995, where his research involved studies of heregulin, HER2, and the anti-HER2 monoclonal antibody trastuzumab (Herceptin�). Dr. Park is also Associate Clinical Professor of Medicine and Principal Investigator in the UCSF Neuro-Oncology Program.

Education

Stanford University School of Medicine, MD, 1982-1986

Residencies

Internal Medicine, UCLA Medical Center, 1986-1989

Fellowships

Medical Oncology & Hematology, UCSF, 1989-1992